Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
| Autor: | Rankin, Stephen, Elyan, Benjamin, Jones, Robert, Venugopal, Balaji, Mark, Patrick B., Lees, Jennifer S., Petrie, Mark C., Lang, Ninian N. |
|---|---|
| Zdroj: | In JACC: CardioOncology April 2024 6(2):267-279 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|